Nuheara Limited announced key Executive appointments and associated restructure of its senior executive team. These changes cement the Company's transformation over the past two years into a medical device manufacturer of world-first US FDA-cleared Over The Counter (OTC) Hearing Aids. The following appointments have been made to Nuheara's senior executive team: Christophe Chene as SVP Strategic Growth based in Taiwan.

Christophe had been contracting to the Company since CES in January 2023 and has 30-years' experience in driving large OEM/ODM deals in the semi-conductor industry and brings a wealth of knowledge and contacts to spearhead Nuheara's business to business initiatives. The Company also plans to strengthen its medical device compliance and regulatory capabilities, currently undertaking a search process for a Head of Compliance, Regulatory and Legal. The following executive reassignments have been undertaken: Dr. Alan Davis, formerly Chief Product officer (CPO) has been appointed Chief Technology Officer (CTO), a role more fitting of the technology expertise he and his team provides across both retail and strategic opportunities.

Nick O'Loughlin, formerly Chief Innovation Officer (CIO) has been appointed Chief Operations Officer (COO). Nick's prior knowledge of new products and offshore manufacturing with SharkNinja provides the business with the necessary experience for scale up. Tony Sulsona, VP Sales and Marketing based in the US, will continue to manage the sales and marketing initiatives for HP Hearing PRO OTC Hearing Aids as Nuheara further builds out its retailer partner network in the US.